FDA warns Dr Retter Ec Wladyslaw Retter over manufacturing failures for homeopathic drug cream.
What happened
FDA reviewed records the firm submitted after a June 2, 2021, request for records; no inspection dates are given. FDA found no process validation data for a homeopathic cream and a label concentration that was about 4 C different from the batch record—about 100,000,000 times the active concentration. It also found no specific identity test for incoming components, incomplete batch records, and inadequate microbial specifications.
What FDA found
The firm lacked adequate written production and process control procedures and did not follow them; its homeopathic cream was distributed without process validation, and the label's dilution did not match the batch record by about 4 C.
21 CFR 211.100(a) and (b)The firm did not conduct at least one specific identity test for each component lot, relying instead on organoleptic examination or the supplier's certificate of analysis.
21 CFR 211.84(d)(1)Batch production and control records did not document significant steps, including equipment identity, step durations, total batch duration, and who performed each step.
21 CFR 211.188(b)Laboratory controls lacked scientifically sound microbial specifications; the COA did not show total aerobic microbial count testing per USP <61> and had no justification for the yeast and mold limit.
21 CFR 211.160(b)
What FDA wants
FDA asks the firm to respond in writing within 15 working days describing corrections and prevention, including validation, component identity testing, batch records, and lab controls; if actions cannot be completed, give reasons and a schedule. FDA also strongly recommends a qualified CGMP consultant.
Who should pay attention
- U.S. distributors and brands importing OTC or homeopathic drugs from Poland
- contract manufacturers and suppliers of homeopathic drug products
- quality teams handling process validation, component identity testing, and microbial testing
This is a summary. Read the original letter on fda.gov.